Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 8 |
GO:0110165 | cellular anatomical entity | 1 | 8 |
Related structures:
AlphaFold database: A0A3S5H5V0
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_MEL_PAP_1 | 111 | 117 | PF00089 | 0.221 |
CLV_NRD_NRD_1 | 20 | 22 | PF00675 | 0.415 |
CLV_NRD_NRD_1 | 24 | 26 | PF00675 | 0.441 |
CLV_PCSK_KEX2_1 | 11 | 13 | PF00082 | 0.456 |
CLV_PCSK_KEX2_1 | 167 | 169 | PF00082 | 0.459 |
CLV_PCSK_KEX2_1 | 19 | 21 | PF00082 | 0.412 |
CLV_PCSK_PC1ET2_1 | 11 | 13 | PF00082 | 0.419 |
CLV_PCSK_PC1ET2_1 | 167 | 169 | PF00082 | 0.513 |
CLV_PCSK_PC1ET2_1 | 19 | 21 | PF00082 | 0.452 |
DOC_MAPK_DCC_7 | 125 | 134 | PF00069 | 0.411 |
DOC_MAPK_MEF2A_6 | 125 | 134 | PF00069 | 0.451 |
DOC_MAPK_MEF2A_6 | 199 | 208 | PF00069 | 0.494 |
DOC_MAPK_MEF2A_6 | 53 | 62 | PF00069 | 0.467 |
DOC_MAPK_NFAT4_5 | 199 | 207 | PF00069 | 0.510 |
DOC_PP1_RVXF_1 | 154 | 161 | PF00149 | 0.611 |
DOC_PP2B_PxIxI_1 | 55 | 61 | PF00149 | 0.300 |
DOC_PP4_FxxP_1 | 93 | 96 | PF00568 | 0.686 |
DOC_USP7_MATH_2 | 96 | 102 | PF00917 | 0.457 |
DOC_WW_Pin1_4 | 151 | 156 | PF00397 | 0.509 |
DOC_WW_Pin1_4 | 47 | 52 | PF00397 | 0.711 |
LIG_14-3-3_CanoR_1 | 114 | 123 | PF00244 | 0.519 |
LIG_14-3-3_CanoR_1 | 159 | 165 | PF00244 | 0.726 |
LIG_Actin_WH2_2 | 146 | 161 | PF00022 | 0.506 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.596 |
LIG_BRCT_BRCA1_1 | 153 | 157 | PF00533 | 0.575 |
LIG_deltaCOP1_diTrp_1 | 75 | 82 | PF00928 | 0.243 |
LIG_eIF4E_1 | 137 | 143 | PF01652 | 0.341 |
LIG_FAT_LD_1 | 200 | 208 | PF03623 | 0.525 |
LIG_FHA_1 | 103 | 109 | PF00498 | 0.303 |
LIG_FHA_1 | 37 | 43 | PF00498 | 0.746 |
LIG_FHA_1 | 50 | 56 | PF00498 | 0.655 |
LIG_LIR_Apic_2 | 117 | 123 | PF02991 | 0.474 |
LIG_LIR_Gen_1 | 154 | 164 | PF02991 | 0.723 |
LIG_LIR_Gen_1 | 181 | 192 | PF02991 | 0.620 |
LIG_LIR_Gen_1 | 31 | 42 | PF02991 | 0.688 |
LIG_LIR_Gen_1 | 97 | 107 | PF02991 | 0.519 |
LIG_LIR_Nem_3 | 154 | 160 | PF02991 | 0.664 |
LIG_LIR_Nem_3 | 181 | 187 | PF02991 | 0.631 |
LIG_LIR_Nem_3 | 31 | 37 | PF02991 | 0.686 |
LIG_LIR_Nem_3 | 75 | 79 | PF02991 | 0.349 |
LIG_LIR_Nem_3 | 97 | 102 | PF02991 | 0.482 |
LIG_NRBOX | 199 | 205 | PF00104 | 0.525 |
LIG_NRBOX | 58 | 64 | PF00104 | 0.341 |
LIG_NRBOX | 84 | 90 | PF00104 | 0.365 |
LIG_SH2_CRK | 120 | 124 | PF00017 | 0.436 |
LIG_SH2_NCK_1 | 120 | 124 | PF00017 | 0.477 |
LIG_SH2_PTP2 | 137 | 140 | PF00017 | 0.375 |
LIG_SH2_PTP2 | 152 | 155 | PF00017 | 0.432 |
LIG_SH2_SRC | 34 | 37 | PF00017 | 0.686 |
LIG_SH2_STAT5 | 137 | 140 | PF00017 | 0.365 |
LIG_SH2_STAT5 | 149 | 152 | PF00017 | 0.292 |
LIG_SH2_STAT5 | 217 | 220 | PF00017 | 0.393 |
LIG_SH2_STAT5 | 34 | 37 | PF00017 | 0.686 |
LIG_SH2_STAT5 | 77 | 80 | PF00017 | 0.305 |
LIG_SH3_3 | 124 | 130 | PF00018 | 0.442 |
LIG_SH3_3 | 62 | 68 | PF00018 | 0.332 |
LIG_SUMO_SIM_anti_2 | 198 | 204 | PF11976 | 0.596 |
LIG_SUMO_SIM_anti_2 | 33 | 39 | PF11976 | 0.685 |
LIG_TYR_ITIM | 135 | 140 | PF00017 | 0.349 |
LIG_TYR_ITIM | 215 | 220 | PF00017 | 0.393 |
MOD_CDC14_SPxK_1 | 50 | 53 | PF00782 | 0.668 |
MOD_CDK_SPK_2 | 151 | 156 | PF00069 | 0.509 |
MOD_CDK_SPxK_1 | 47 | 53 | PF00069 | 0.676 |
MOD_CK1_1 | 101 | 107 | PF00069 | 0.372 |
MOD_CK1_1 | 2 | 8 | PF00069 | 0.675 |
MOD_CK2_1 | 2 | 8 | PF00069 | 0.621 |
MOD_Cter_Amidation | 165 | 168 | PF01082 | 0.436 |
MOD_GlcNHglycan | 172 | 175 | PF01048 | 0.461 |
MOD_GSK3_1 | 45 | 52 | PF00069 | 0.697 |
MOD_GSK3_1 | 63 | 70 | PF00069 | 0.194 |
MOD_GSK3_1 | 94 | 101 | PF00069 | 0.658 |
MOD_NEK2_1 | 158 | 163 | PF00069 | 0.716 |
MOD_NEK2_1 | 63 | 68 | PF00069 | 0.407 |
MOD_NEK2_1 | 91 | 96 | PF00069 | 0.468 |
MOD_PKA_2 | 113 | 119 | PF00069 | 0.545 |
MOD_PKA_2 | 158 | 164 | PF00069 | 0.625 |
MOD_PKA_2 | 169 | 175 | PF00069 | 0.595 |
MOD_PKA_2 | 45 | 51 | PF00069 | 0.694 |
MOD_PKB_1 | 168 | 176 | PF00069 | 0.653 |
MOD_Plk_4 | 102 | 108 | PF00069 | 0.299 |
MOD_Plk_4 | 54 | 60 | PF00069 | 0.414 |
MOD_Plk_4 | 84 | 90 | PF00069 | 0.342 |
MOD_ProDKin_1 | 151 | 157 | PF00069 | 0.509 |
MOD_ProDKin_1 | 47 | 53 | PF00069 | 0.711 |
TRG_DiLeu_BaEn_1 | 198 | 203 | PF01217 | 0.640 |
TRG_DiLeu_BaEn_4 | 195 | 201 | PF01217 | 0.709 |
TRG_DiLeu_BaLyEn_6 | 127 | 132 | PF01217 | 0.514 |
TRG_DiLeu_BaLyEn_6 | 232 | 237 | PF01217 | 0.448 |
TRG_ENDOCYTIC_2 | 137 | 140 | PF00928 | 0.321 |
TRG_ENDOCYTIC_2 | 184 | 187 | PF00928 | 0.610 |
TRG_ENDOCYTIC_2 | 217 | 220 | PF00928 | 0.360 |
TRG_ENDOCYTIC_2 | 34 | 37 | PF00928 | 0.686 |
TRG_Pf-PMV_PEXEL_1 | 40 | 44 | PF00026 | 0.502 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PBC2 | Leptomonas seymouri | 68% | 100% |
A0A0S4JA41 | Bodo saltans | 29% | 100% |
A0A1X0NGU0 | Trypanosomatidae | 38% | 100% |
A4H4T7 | Leishmania braziliensis | 85% | 100% |
A4HT17 | Leishmania infantum | 100% | 100% |
C9ZTQ4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 35% | 100% |
E9AL05 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 94% | 100% |
Q4QIV0 | Leishmania major | 95% | 100% |